top of page
Blog Posts
Search


The $10 billion unicorn in INmune Bio: cognition matters - on EMACC, CDR-SB, and why others may have failed
Summary Alzheimer’s is a disease of slowly fading cognition. If you would ask me how much my grandmother’s Alzheimer’s progressed over...
Carl Kestens
6 days ago15 min read
317 views
1 comment


The $10 billion unicorn in INmune Bio: on BioVie teachings and trustworthiness
Summary BioVie always argued that it saw a correlation between effects on cognition and reduction of TNF levels. That TNF reduction...
Carl Kestens
Mar 1410 min read
342 views
2 comments


The $10 billion unicorn in INmune Bio: Leqembi and Kisunla’s MoA is microglia-related, and amyloid beta is a cytokine
Introduction Amyloid beta has been the primary hallmark of Alzheimer’s disease for years. On the one hand, numerous trials focusing on...
Carl Kestens
Mar 615 min read
359 views
13 comments

The $10 billion unicorn in INmune Bio: where fraud and arrogance aren’t, solutions to AD are (C. Piller book coverage)
Introduction Science journalist Charles Piller wrote a book, called ‘Doctored: fraud, arrogance, and tragedy in the quest to cure...
Carl Kestens
Feb 2810 min read
360 views
1 comment
bottom of page